Bryan Giraudo, Director at Protagonist Therapeutics, Inc (PTGX), bought 10,000 shares at $6.46 ($65K) on 2017-05-16, disclosed to the SEC on 2018-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GOSS | SELL | 2024-03-28 | $7K | — | Filing → |
| GOSS | BUY | 2023-11-14 | $224K | — | Filing → |
| GOSS | BUY | 2023-04-05 | $56K | — | Filing → |